Wednesday, June 10, 2026
🇺🇸 FDA

pharma · RSV Infection · NASH - Nonalcoholic Steatohepatitis · ENTA

ENANTA PHARMACEUTICALS

ENANTA PHARMACEUTICALS INC

ENANTA PHARMACEUTICALS patent portfolio — 218 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
4 Kingsbury Ave, Watertown, Massachusetts 02472, US HQ
1995 Founded
145 Employees
Public company Type
ENTA · NYSE Ticker
Company details
Status
Public
HQ
4 Kingsbury Ave, Watertown, Massachusetts 02472, US
Founded
1995
Employees
145
Programs
34
Drugs
15
Patents
218
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

ENANTA PHARMACEUTICALS patents

218 pharmaceutical patents indexed for ENANTA PHARMACEUTICALS. 9 expire within 24 months.

ENANTA PHARMACEUTICALS has 218 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 9 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

218 patents

Patent portfolio

Page 5 of 5

  1. US 7273853

    6-11 bicyclic ketolide derivatives

    Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7273851

    Tri-peptide hepatitis C serine protease inhibitors

    Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7229972

    3,6-Bicyclolides

    Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7189704

    6-11 bicyclic ketolide derivatives

    Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7176208

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7129221

    6,11-bicyclic erythromycin derivatives

    Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7125845

    Aza-peptide macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7049417

    6,11-4-Carbon bridged ketolides

    Expires Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 7012065

    Cyclosporins for the treatment of immune disorders

    Expires Mon Mar 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 7012064

    Cyclosporins for the treatment of immune disorders

    Expires Mon Mar 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6979671

    Cyclosporins for the treatment of immune disorders

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6878691

    6-11 bicyclic ketolide derivatives

    Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6841664

    6,11-4-carbon bridged ketolides

    Expires Mon Jan 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6812216

    11-C-substituted derivatives of clarithromycin

    Expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6809077

    Cyclosporin analogs for the treatment of autoimmune diseases

    Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6784156

    Cyclosporins for the treatment of respiratory diseases

    Expires Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6764998

    6,11-4C-bicyclic 9a-azalide derivatives

    Expires Mon Jul 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6765016

    Bicyclic ketolide derivatives

    Expires Mon Jul 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6753415

    23-O-substituted 5-O-mycaminosyltylonide derivatives

    Expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6750204

    11-C-substituted ketolides

    Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6720308

    Anhydrolide derivatives having antibacterial activity

    Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6710034

    5-O-mycaminosyltylonide derivatives

    Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6680299

    4'-substituted leucomycins

    Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6645941

    6,11-3C-bicyclic 9a-azalide derivatives

    Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6440942

    14-membered macrolides derived from leucomycins

    Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6436906

    9-amino-14-membered macrolides derived from leucomycins

    Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does ENANTA PHARMACEUTICALS have?

218 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ENANTA PHARMACEUTICALS patents expire?

9 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.